×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2026半年會
摘要
2025年會 (UAA)
摘要
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
PD9-4: Long-term functional outcome by (effective renal plasma flow) ERPF after blunt renal trauma(BRT) with or without transarterial embolization (TAE)
2018-07-06
PD9-2: The relationship among levels of plasma folate, global DNA hypomethylation, and the disease-free survival of urothelial carcinoma
2018-07-06
PD9-1: The prothymosin-α modifies microRNA to induce cachexia in bladder cancers
2018-07-06
PD8-6: MJ-56, a novel quinazolin derivative, emits green fluorescent and exhibits phtotoxicity toward human bladder cancer cells
2018-07-06
PD8-5: Prognostic value of leptin receptor overexpression in upper tract urothelial carcinomas in taiwan.
2018-07-06
PD8-3: Mir-30a isomirs targets multiple autophagy related genes and sensitizes human bladder cancer cells to cisplatin treatment
2018-07-06
PD8-4: Analysis of simultaneous transurethral resection of bladder cancer and prostate in non-muscle invasive bladder urothelial carcinoma patients.
2018-07-06
PD8-1: Quercetin induces protective autophagy in human bladder cancer cells
2018-07-06
PD8-2: Miconazole, an anti-fungal agent, induces autophagy via reactive oxygen species in human bladder cancer cells
2018-07-06
PD7-5: Identification of potential genes in upper tract urothelial carcinoma by using next-generation sequencing and bioinformatics analysis
2018-07-06
PD7-6: Application of risk models to predict outcomes in non-muscle invasive bladder urothelial carcinoma patient after transurethral tumor resection- external validation in Taiwan
2018-07-06
PD7-4: The prognostic impact of DDR2 overexpression in patients with urothelial carcinoma
2018-07-06
PD7-2: Medium-term outcomes after whole-gland high-intensity focused ultrasound for the treatment of localized prostate cancer: A single institution experience
2018-07-06
PD7-3: Management of mCRPC with second-line hormone therapies: A single-hospital experience
2018-07-06
PD7-1: Oncological results of radical prostatectomy in high risk group prostate patients: real world experience from Taiwan population
2018-07-06
PD6-6: Analysis the effect of intraoperative frozen-section analysis and multiparametric magnetic resonance imaging in patients of prostate cancer undergoing robotic-assisted radical prostatectomy can reduce the rate of positive surgical margins or not
2018-07-06
PD6-4: Continence outcome in retzius-sparing robotic-assisted radical prostatectomy with neurovascular bundle preserving
2018-07-06
PD6-5: Evaluation of prostate health index for the detection of prostate cancer-preliminary results in wan fang hospital
2018-07-06
PD6-2: Multiparametric magnetic resonance imaging increases predictive accuracy of oncological outcomes after robot-assisted radical prostatectomy
2018-07-06
PD6-3: Is trans-perineal prostate biopsy applicable under local anesthesia?a single center preliminary study.
2018-07-06
PD6-1: Robot- assisted radical prostatectomy with three-layer vesicourethral reconstruction improves early urinary continence recovery
2018-07-06
PD5-6: Modified hand-assisted retroperitoneoscopic nephroureterectomy with an adjunctive port for the treatment of upper urinary tract tumor
2018-07-06
PD5-4: To investigate the duration of initial diagnosis of urothelial cell carcinoma and renal tumor in Taiwan patients with dialysis – a nationwide population-based cohort study
2018-07-06
PD5-5: Outcome of patients with T1 renal cell carcinoma received partial nephrectomy: VGHTC experience
2018-07-06
<
105
106
107
108
109
110
111
112
113
114
>
/ 155